Study of AG10 in Amyloid Cardiomyopathy

NCT03458130 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial ATTR-CM (ATTRm-CM, or FAC)
Wild-type ATTR-CM (ATTRwt-CM)

Interventions

DRUG: AG10
DRUG: Placebo Oral Tablet

Sponsor

Eidos Therapeutics, a BridgeBio company